Medical and Pharmaceutical Pulmonx Corporation shares spike on record-breaking Q4 revenue Pulmonx achieved USD$83.8 million in worldwide revenue, reflecting a robust 22 per cent growth over 2023 Joseph MortonFebruary 21, 2025